by AnTolRx | Oct 29, 2019 | Updates
Psoriasis is an autoimmune disease that affects over 125 million people worldwide, that is up to 3% of the total population! At AnTolRx, our targeted approach actively promotes immune tolerance by inducing an anti-inflammatory phenotype and thus better treat disease.... by AnTolRx | Oct 2, 2019 | Updates
We will be presenting data on AnTolRx’s antigen-specific nanoformulation platform. Join us in Woods Hole, MA, on October 12-13th, 2019. http://www.newenglandimmunology.org